During a recent “Forbes Newsroom” segment, Dr. Steven J. Fleischman, President of the American College of Obstetricians and Gynecologists, emphasized that there is currently “no study to date that shows a causal relationship between acetaminophen and autism,” responding to a controversial statement made by President Donald Trump on the use of Tylenol during pregnancy.
Sep 24, 2025, 04:17pm EDT
This past Monday, President Trump advised expectant mothers to steer clear of acetaminophen, claiming it could elevate the chances of autism in developing fetuses. His remarks triggered immediate backlash from several renowned medical associations across the nation.
Dr. Fleischman articulated his concerns during a press conference, noting, “The implications that the use of acetaminophen during pregnancy is linked to autism are deeply troubling for healthcare professionals and could send dangerous, mixed messages to pregnant individuals, particularly to those who may already need this essential medication.” He elaborated on Monday.
In a follow-up discussion with ForbesWomen’s editor Maggie McGrath, Dr. Fleischman reiterated the scientific consensus regarding acetaminophen and autism. “Extensive research has been conducted to explore a possible correlation between acetaminophen use and autism, but thus far, no evidence has substantiated that claim,” he stated. “To date, no credible studies have demonstrated a causal link between acetaminophen and autism.”
Addressing the president’s suggestion for pregnant individuals to endure fever symptoms, Dr. Fleischman cautioned against this approach: “There are established studies indicating that high fevers can lead to birth abnormalities. Ignoring a significant fever is dangerous; that is reckless advice, and it could harm both the mother and the developing fetus.”
For a comprehensive view of their conversation, please click here or watch the embedded video above.
